Similarly, in colorectal cancer (CRC), a risk score based on 19 genes transcriptionally regulated by TREM-1 and/or CTGF activation was found to be an independent risk factor for cancer recurrence and a significant prognostic indicator that may associate with reduced response to adjuvant chemotherapy (68). This evidence concerns the gene TREM1 and colorectal carcinoma.